Alexion's Acquisition of Synageva
Scroll to keep reading
Matthew Hurd, Legal counsel to Synageva
Alexion Pharmaceuticals will buy rival Synageva BioPharma in an $8.4 billion cash-and-stock deal that will bolster Alexion’s business in treatments for rare diseases.
Alexion’s takeover offer is aggressive: It will pay $115 in cash and 0.6581 Alexion shares for each share of Synageva, amounting to $230 in cash and stock.
InnovationRuStyle is an award-winning London-based PR company with an independent full-service public relation, consulting and development agency specialising in leading luxury fashion, jewellery, beauty, lifestyle, health and fitness brands. We caught up with the RuSty
M&AWhen private equity firms complete an acquisition, their focus shifts sharply from deal-making to value creation. While growth targets, operational efficiencies, and strategic realignments dominate integration plans, one foundational element often determines s
FinanceMost of us take it for granted these days, but the rate of technological change in the past decade or more is astonishing. Super-fast internet, cloud storage, video streaming; just imagine what things will be like a decade from now.
LeadershipFollowing the transfer of sovereignty in 1997, Hong Kong found itself in a precarious situation. In both a political and economic sense, there arose a dire need for direction from any who were willing to provide it. Enter Anthony Siu & Co., a Hong Kong-based l
M&AFranklin advises Altice for the sale of stakes in its French and Portuguese telecom tower business
M&AE-House (China) Holdings Limited, a leading real estate services company in China, today announced that it has entered into a definitive Agreement and Plan of with E-House Holdings Ltd. and E-House Merger Sub Ltd.
FinanceConsumers are set to spend £53.6 billion a year using their smartphones and tablets by 2024, compared with the £9.7 billion spent today, according to new research by Barclays.
NewsIt’s incredibly difficult to develop a successful business and a thriving team without accountability, yet so many businesses neglect to develop this aspect of their workplace culture. If no-one (even in the leadership team) takes ownership of their responsi
LeadershipFineHeart is a French medical device company focused on creating innovative technologies in the cardiovascular space.
Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.
